Barrow, Hanley, Mewhinney & Strauss’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $353M | Sell |
4,071,177
-104,681
| -3% | -$10M | 1.16% | 29 |
|
|
2025
Q4 | $401M | Sell |
4,175,858
-223,430
| -5% | -$21.7M | 1.34% | 32 |
|
|
2025
Q3 | $419M | Buy |
4,399,288
+647
| +0% | +$59.5K | 1.33% | 30 |
|
|
2025
Q2 | $383M | Sell |
4,398,641
-16,830
| -0.4% | -$1.43M | 1.29% | 31 |
|
|
2025
Q1 | $397M | Buy |
4,415,471
+884,964
| +25% | +$79.2M | 1.44% | 25 |
|
|
2024
Q4 | $282M | Sell |
3,530,507
-69,594
| -2% | -$6.02M | 0.96% | 42 |
|
|
2024
Q3 | $324M | Sell |
3,600,101
-2,390,558
| -40% | -$201M | 1.06% | 37 |
|
|
2024
Q2 | $472M | Sell |
5,990,659
-236,885
| -4% | -$19.4M | 1.61% | 20 |
|
|
2024
Q1 | $543M | Sell |
6,227,544
-206,147
| -3% | -$17.6M | 1.83% | 17 |
|
|
2023
Q4 | $530M | Buy |
6,433,691
+220,431
| +4% | +$16.8M | 1.86% | 17 |
|
|
2023
Q3 | $487M | Buy |
6,213,260
+43,345
| +0.7% | +$3.63M | 1.86% | 16 |
|
|
2023
Q2 | $544M | Buy |
6,169,915
+127,261
| +2% | +$11M | 2.02% | 13 |
|
|
2023
Q1 | $487M | Buy |
6,042,654
+328,728
| +6% | +$26.8M | 1.89% | 12 |
|
|
2022
Q4 | $444M | Sell |
5,713,926
-172,238
| -3% | -$14M | 1.67% | 21 |
|
|
2022
Q3 | $475M | Sell |
5,886,164
-100,623
| -2% | -$9.04M | 1.95% | 16 |
|
|
2022
Q2 | $537M | Buy |
5,986,787
+1,091,531
| +22% | +$111M | 2.03% | 12 |
|
|
2022
Q1 | $543M | Buy |
4,895,256
+2,435,008
| +99% | +$257M | 1.77% | 21 |
|
|
2021
Q4 | $255M | Sell |
2,460,248
-193,805
| -7% | -$22.4M | 0.8% | 48 |
|
|
2021
Q3 | $333M | Sell |
2,654,053
-1,097,427
| -29% | -$142M | 1.1% | 39 |
|
|
2021
Q2 | $466M | Sell |
3,751,480
-1,200,434
| -24% | -$151M | 1.5% | 30 |
|
|
2021
Q1 | $585M | Sell |
4,951,914
-308,901
| -6% | -$36.2M | 1.86% | 14 |
|
|
2020
Q4 | $616M | Sell |
5,260,815
-1,104,664
| -17% | -$122M | 2.12% | 7 |
|
|
2020
Q3 | $662M | Sell |
6,365,479
-149,016
| -2% | -$15M | 2.55% | 2 |
|
|
2020
Q2 | $597M | Sell |
6,514,495
-921,464
| -12% | -$88.4M | 2.34% | 5 |
|
|
2020
Q1 | $671M | Sell |
7,435,959
-52,520
| -0.7% | -$5.59M | 3.07% | 1 |
|
|
2019
Q4 | $850M | Sell |
7,488,479
-5,926,047
| -44% | -$650M | 2.72% | 1 |
|
|
2019
Q3 | $1.46B | Sell |
13,414,526
-1,085,339
| -7% | -$113M | 2.86% | 3 |
|
|
2019
Q2 | $1.41B | Buy |
14,499,865
+1,251,830
| +9% | +$114M | 2.57% | 9 |
|
|
2019
Q1 | $1.21B | Buy |
13,248,035
+1,354,885
| +11% | +$121M | 2.17% | 12 |
|
|
2018
Q4 | $1.08B | Sell |
11,893,150
-439,001
| -4% | -$41M | 2.12% | 17 |
|
|
2018
Q3 | $1.21B | Sell |
12,332,151
-2,257,350
| -15% | -$209M | 1.93% | 21 |
|
|
2018
Q2 | $1.25B | Sell |
14,589,501
-651,119
| -4% | -$54.4M | 2.01% | 15 |
|
|
2018
Q1 | $1.22B | Sell |
15,240,620
-457,947
| -3% | -$37.8M | 1.94% | 17 |
|
|
2017
Q4 | $1.27B | Sell |
15,698,567
-875,680
| -5% | -$70.1M | 1.89% | 24 |
|
|
2017
Q3 | $1.29B | Sell |
16,574,247
-3,111,277
| -16% | -$258M | 1.94% | 22 |
|
|
2017
Q2 | $1.75B | Sell |
19,685,524
-520,335
| -3% | -$43.9M | 2.65% | 6 |
|
|
2017
Q1 | $1.63B | Sell |
20,205,859
-322,736
| -2% | -$25.2M | 2.45% | 7 |
|
|
2016
Q4 | $1.46B | Buy |
20,528,595
+1,495,147
| +8% | +$117M | 2.19% | 14 |
|
|
2016
Q3 | $1.64B | Sell |
19,033,448
-2,056,814
| -10% | -$179M | 2.5% | 4 |
|
|
2016
Q2 | $1.83B | Sell |
21,090,262
-6,404,245
| -23% | -$518M | 2.79% | 3 |
|
|
2016
Q1 | $2.06B | Sell |
27,494,507
-2,787,612
| -9% | -$210M | 3.15% | 1 |
|
|
2015
Q4 | $2.33B | Sell |
30,282,119
-685,008
| -2% | -$51.6M | 3.47% | 1 |
|
|
2015
Q3 | $2.07B | Sell |
30,967,127
-649,558
| -2% | -$47.8M | 3.19% | 2 |
|
|
2015
Q2 | $2.34B | Sell |
31,616,685
-272,478
| -0.9% | -$20.8M | 3.19% | 2 |
|
|
2015
Q1 | $2.49B | Sell |
31,889,163
-749,291
| -2% | -$56.8M | 3.38% | 1 |
|
|
2014
Q4 | $2.36B | Buy |
32,638,454
+158,606
| +0.5% | +$11M | 3.15% | 2 |
|
|
2014
Q3 | $2.01B | Buy |
32,479,848
+139,614
| +0.4% | +$8.88M | 2.74% | 3 |
|
|
2014
Q2 | $2.06B | Buy |
32,340,234
+622,025
| +2% | +$37.8M | 2.77% | 2 |
|
|
2014
Q1 | $1.95B | Sell |
31,718,209
-924,241
| -3% | -$53.8M | 2.79% | 3 |
|
|
2013
Q4 | $1.87B | Buy |
32,642,450
+315,317
| +1% | +$17.9M | 2.71% | 7 |
|
|
2013
Q3 | $1.72B | Buy |
32,327,133
+82,111
| +0.3% | +$4.42M | 2.75% | 4 |
|
|
2013
Q2 | $1.66B | Buy |
+32,245,022
| New | +$1.59B | 2.79% | 5 |
|
Other funds holding MDT
VCM
VPM
Barrow, Hanley, Mewhinney & Strauss's MDT Position: Q1 2026 in Review
Barrow, Hanley, Mewhinney & Strauss reduced its Medtronic (MDT) stake by 2.5% in Q1 2026, selling an estimated $10M and leaving 4,071,177 shares worth $353M. The position accounts for 1.16% of the portfolio, ranked #29.
Barrow, Hanley, Mewhinney & Strauss first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.49B in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss held 4,071,177 shares of Medtronic worth $353M as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss sold 104,681 Medtronic shares in Q1 2026, an estimated $10M.
- Medtronic made up 1.16% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #29 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's Medtronic position peaked at $2.49B in Q1 2015.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.